Subscribe To
Oncternal Therapeutics to Participate at the 2023 Jefferies Healthcare Conference
SAN DIEGO, May 31, 2023 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that Dr. James Breitmeyer, Oncternal’s President and Chief Executive Officer will present at the 2023 Jefferies Healthcare Conference. 2023 Jefferies Healthcare ConferenceDate: Wednesday, June 7, 2023 at 4:30pm […] The post Oncternal Therapeutics to Participate at the 2023 Jefferies Healthcare Co...
Read More
Posted: May 31 2023, 21:00
Author Name: forextv
Views: 110645